Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Achieve Life Sciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +13 vs. Q1 2021
- Shares held
- 1.95M
- +941.3K (+93.5%) vs. Q1 2021
- Total value
- $17.5M
- +$5.84M (+50.1%) vs. Q1 2021
- New holders
- 17
- 8 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shay Capital LLC | 403,075 | $3.62M | 0.86% | +268,075+198.6% | Added |
| Vanguard Group Inc | 248,882 | $2.24M | 0.00% | −47,067−15.9% | Reduced |
| Perkins Capital Management Inc | 172,100 | $1.54M | 0.88% | +131,500+323.9% | Added |
| Morgan Stanley | 139,200 | $1.25M | 0.00% | +51,654+59.0% | Added |
| 683 Capital Management, LLC | 125,000 | $1.12M | 0.06% | +125,000 | New |
| Altium Capital Management LP | 122,000 | $1.10M | 0.25% | +122,000 | New |
| Clearline Capital LP | 121,812 | $1.09M | 0.16% | +121,812 | New |
| Millennium Management LLC | 101,986 | $916.0K | 0.00% | +101,986 | New |
| Renaissance Technologies LLC | 76,960 | $691.0K | 0.00% | +54,899+248.9% | Added |
| LPL Financial LLC | 68,800 | $618.0K | 0.00% | +15,900+30.1% | Added |
| Geode Capital Management, LLC | 56,669 | $508.0K | 0.00% | +27,379+93.5% | Added |
| Two Sigma Investments, LP | 44,419 | $399.0K | 0.00% | +44,419 | New |
| Two Sigma Advisers, LP | 43,255 | $388.0K | 0.00% | +43,255 | New |
| QS Investors, LLC | 34,050 | $306.0K | 0.00% | +34,050 | New |
| Royal Bank of Canada | 30,700 | $276.0K | 0.00% | +30,700 | New |
| Dimensional Fund Advisors LP | 27,493 | $247.0K | 0.00% | +27,493 | New |
| Walleye Capital LLC | 27,307 | $245.0K | 0.01% | +27,307 | New |
| Oppenheimer & Co Inc | 23,000 | $207.0K | 0.00% | +23,000 | New |
| Occudo Quantitative Strategies LP | 19,082 | $171.0K | 0.03% | +19,082 | New |
| Northern Trust Corp | 17,096 | $153.0K | 0.00% | +17,096 | New |
| Pura Vida Investments, LLC | 17,000 | $153.0K | 0.01% | +17,000 | New |
| State Street Corp | 14,761 | $133.0K | 0.00% | +14,761 | New |
| Paradigm Financial Partners, LLC | 11,350 | $102.0K | 0.03% | +250+2.3% | Added |
| Wells Fargo & Company | 893 | $8.00K | 0.00% | +570+176.5% | Added |
| UBS Group AG | 589 | $6.00K | 0.00% | +589 | New |
| Tower Research Capital LLC (TRC) | 308 | $3.00K | 0.00% | −1,071−77.7% | Reduced |
| BlackRock Inc. | 327 | $3.00K | 0.00% | −58−15.1% | Reduced |
| Newbridge Financial Services Group, Inc. | 308 | $3.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −284,151−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −33,389−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,456−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |